ZA201903696B - Compositions for use in treating inflammatory bowel diseases and intestinal colitis - Google Patents
Compositions for use in treating inflammatory bowel diseases and intestinal colitisInfo
- Publication number
- ZA201903696B ZA201903696B ZA2019/03696A ZA201903696A ZA201903696B ZA 201903696 B ZA201903696 B ZA 201903696B ZA 2019/03696 A ZA2019/03696 A ZA 2019/03696A ZA 201903696 A ZA201903696 A ZA 201903696A ZA 201903696 B ZA201903696 B ZA 201903696B
- Authority
- ZA
- South Africa
- Prior art keywords
- compositions
- inflammatory bowel
- bowel diseases
- treating inflammatory
- intestinal colitis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/606—Salicylic acid; Derivatives thereof having amino groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762447892P | 2017-01-18 | 2017-01-18 | |
| US201762567889P | 2017-10-04 | 2017-10-04 | |
| PCT/US2018/013035 WO2018136266A1 (en) | 2017-01-18 | 2018-01-09 | Compositions for use in treating inflammatory bowel diseases and intestinal colitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201903696B true ZA201903696B (en) | 2021-09-29 |
Family
ID=62838452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2019/03696A ZA201903696B (en) | 2017-01-18 | 2019-06-10 | Compositions for use in treating inflammatory bowel diseases and intestinal colitis |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10130605B2 (en) |
| EP (1) | EP3570825A4 (en) |
| JP (1) | JP7084930B2 (en) |
| KR (1) | KR102471786B1 (en) |
| CN (1) | CN110177547B (en) |
| AU (1) | AU2018210771B2 (en) |
| BR (1) | BR112019014761A2 (en) |
| CA (1) | CA3049125C (en) |
| TW (1) | TWI766931B (en) |
| WO (1) | WO2018136266A1 (en) |
| ZA (1) | ZA201903696B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT202000004939A1 (en) * | 2020-03-09 | 2021-09-09 | Palu Giorgio | Uses of 1,8-dihydroxy-3- [hydroxymethyl] -antraquinone and its derivatives |
| WO2023090313A1 (en) * | 2021-11-16 | 2023-05-25 | 京都府公立大学法人 | Composition for increasing amount of food ingested and/or improving anorexia, and composition for activating transient receptor potential ankyrin 1 |
| CN115192559A (en) * | 2022-07-20 | 2022-10-18 | 昆明理工大学 | Application of methyl isoalizarin in preparation of medicine for treating intestinal mucosa injury |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050090553A1 (en) * | 1992-06-30 | 2005-04-28 | Shapiro Howard K. | Compositions and method for treatment of chronic inflammatory diseases |
| EP0759750A4 (en) * | 1994-05-11 | 1998-05-27 | Howard K Shapiro | Compositions for treatment of chronic inflammatory diseases |
| US20020128317A1 (en) * | 2001-01-23 | 2002-09-12 | Laboratories Negma | Treatment of pathological conditions characterized by an increased IL-1 level |
| EP3115057B1 (en) * | 2004-10-21 | 2019-09-04 | ONO Pharmaceutical Co., Ltd. | Use of immunesuppressant receptor |
| KR20080096705A (en) | 2006-04-07 | 2008-10-31 | 선 텐 피토테크 컴퍼니 리미티드 | Anthracenedione compounds |
| EP2476416A1 (en) * | 2006-11-17 | 2012-07-18 | Shire Development Inc. | Method of Treatment for Inflammatory Bowel Disease |
| WO2009047801A1 (en) * | 2007-10-10 | 2009-04-16 | Lupin Limited | Therapeutic combinations and compositions for the treatment of gastrointestinal disorders |
| TWI473610B (en) * | 2008-10-28 | 2015-02-21 | Twi Biotechnology Inc | Pharmaceutical compositions containing diacerein |
| CN105748655A (en) * | 2014-12-31 | 2016-07-13 | 陈深源 | Method for enhanced production of morinda metabolites |
| TWI743047B (en) | 2015-08-17 | 2021-10-21 | 安成生物科技股份有限公司 | Methods for inhibiting expression of asc, expression of nlrp3, and/or formation of nlrp3 inflammasome complex using diacerein or its analogs |
-
2018
- 2018-01-09 WO PCT/US2018/013035 patent/WO2018136266A1/en unknown
- 2018-01-09 EP EP18741911.4A patent/EP3570825A4/en active Pending
- 2018-01-09 JP JP2019534758A patent/JP7084930B2/en active Active
- 2018-01-09 CN CN201880006116.2A patent/CN110177547B/en active Active
- 2018-01-09 KR KR1020197024116A patent/KR102471786B1/en active IP Right Grant
- 2018-01-09 BR BR112019014761-6A patent/BR112019014761A2/en not_active Application Discontinuation
- 2018-01-09 CA CA3049125A patent/CA3049125C/en active Active
- 2018-01-09 AU AU2018210771A patent/AU2018210771B2/en active Active
- 2018-01-10 US US15/867,201 patent/US10130605B2/en active Active
- 2018-01-12 TW TW107101346A patent/TWI766931B/en active
-
2019
- 2019-06-10 ZA ZA2019/03696A patent/ZA201903696B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018136266A1 (en) | 2018-07-26 |
| CA3049125A1 (en) | 2018-07-26 |
| TWI766931B (en) | 2022-06-11 |
| AU2018210771A1 (en) | 2019-06-27 |
| US20180200217A1 (en) | 2018-07-19 |
| CA3049125C (en) | 2021-11-16 |
| TW201827044A (en) | 2018-08-01 |
| KR102471786B1 (en) | 2022-11-28 |
| KR20190124713A (en) | 2019-11-05 |
| JP7084930B2 (en) | 2022-06-15 |
| JP2020504118A (en) | 2020-02-06 |
| EP3570825A4 (en) | 2020-10-14 |
| EP3570825A1 (en) | 2019-11-27 |
| CN110177547B (en) | 2022-09-27 |
| BR112019014761A2 (en) | 2020-03-03 |
| CN110177547A (en) | 2019-08-27 |
| US10130605B2 (en) | 2018-11-20 |
| AU2018210771B2 (en) | 2020-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3240554T3 (en) | Blautia stercosis and wexlerae for use in treating inflammatory and autoimmune diseases | |
| EP3462882A4 (en) | Compositions and methods for treating inflammatory bowel diseases (ibds) and other disorders | |
| HK1254432A1 (en) | Methods and compositions for treating fibrotic diseases | |
| IL261738A (en) | Method and composition for treating inflammatory bowel disease | |
| HK1256909A1 (en) | Glp-1 and use thereof in compositions for treating metabolic diseases | |
| IL269158A (en) | Compositions and methods for treating inflammatory diseases | |
| IL249098A0 (en) | Methods and compositions for treating allergy and inflammatory diseases | |
| IL247266A0 (en) | Methods for diagnosing and treating inflammatory bowel disease | |
| ZA201903696B (en) | Compositions for use in treating inflammatory bowel diseases and intestinal colitis | |
| IL279859A (en) | Compositions and methods for treating inflammatory bowel disease | |
| HK1254242A1 (en) | Composition for treatment of inflammatory bowel disease and atopic dermatitis | |
| HUE056154T2 (en) | Pectin compositions for preventing and treating inflammatory diseases | |
| GB2537783B (en) | Compositions used in treating inflammatory and autoimmune diseases | |
| HK1245131A1 (en) | Combination comprising palmitoylethanolamide (pea) and lycopene for use in the treatment of inflammatory diseases | |
| IL272604A (en) | Methods and compositions for treatment of inflammatory bowel disease | |
| HK1253274A1 (en) | Thylakoid extract composition and formulation for the treatment of inflammatory bowel disease | |
| SI3548006T1 (en) | Composition for use in the treatment of intestinal alterations | |
| IL259884A (en) | Vaginal inserted estradiol pharmaceutical compositions and methods | |
| HK1248136A1 (en) | Compositions and methods for using lamellar bodies for therapeutic purposes | |
| HUP1500192A2 (en) | Use of mannooligosaccharides for treating human inflammatory bowel diseases | |
| HK1203031A2 (en) | Use of salmonella flagellin derivative in preparation of drug for preventing and treating inflammatory bowel diseases | |
| GB201718856D0 (en) | Medicinal compositions for the treatment of inflammatory conditions and autoimmune diseases | |
| IL250244A0 (en) | Preventing and treating inflammatory skin diseases | |
| GB201701765D0 (en) | Pharmaceutical and cleaning compositions and their use in treatment |